InsiderTrades

Form 4 for TXG 10x Genomics, Inc.

Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-01 · accession 0001567619-21-021614 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2021-12-03 2021-12-01 TXG STUELPNAGEL JOHN R Dir S - Sale $151.16 -5,000 349.6K -1% -$755.8K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-12-01 S D 100 $155.55 346,616 D — —
2 Common Class A Common Stock 2021-12-01 S D 100 $154.02 346,716 D — —
3 Common Class A Common Stock 2021-12-01 S D 1,100 $151.79 346,816 D — — (F4) This transaction was executed in multiple trades at prices ranging from $151.53 to $152.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
4 Common Class A Common Stock 2021-12-01 S D 1,700 $151.10 347,916 D — — (F3) This transaction was executed in multiple trades at prices ranging from $151.00 to $151.30. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
5 Common Class A Common Stock 2021-12-01 S D 2,000 $150.51 349,616 D — — (F2) This transaction was executed in multiple trades at prices ranging from $150.00 to $150.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.